Adicet Bio (ACET) Earnings Date & Reports

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer... Show more

Industry: #Medical Distributors

Get AI intraday signals

A.I. Advisor

published Earnings

ACET is expected to report earnings to rise 15.96% to -218 cents per share on August 06

Q2'26

Est.

$-2.18

Q1'26

Missed

by $1.70

Q4'25

Missed

by $2.65

Q3'25

Beat

by $0.01

Q2'25

Missed

by $0.03

The last earnings report on May 13 showed earnings per share of -187 cents, missing the estimate of -17 cents. With 121.74K shares outstanding, the current market capitalization sits at 75.25M.

View a ticker or compare two or three

Compare

ACET

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ACET